Bacopa: is it safe? Side effects and who should avoid it

For most healthy adults, bacopa appears to be well tolerated at the doses used in studies. Reviews of the plant describe it as generally non-toxic, with no serious side effects reported, though interactions with certain medicines and contraindications in situations such as hyperthyroidism should be considered. That does not make it harmless for everyone: digestive effects are common, some groups have little safety data, and there are signs that mean you should stop.

Below, we look at what trials actually measured, which effects show up, who should speak to a healthcare professional before taking it, and what a bacopa supplement label usually tells you. If you arrived from the general energy and focus page, this is the safety companion to it.

What the studies say about bacopa's safety

Safety evidence comes mainly from short- and medium-term trials. In a phase I study, 23 healthy adult volunteers took 300 mg of a standardised bacopa extract per day for 15 days and 450 mg per day for the following 15 days; analysis of clinical, haematological, biochemical and electrocardiographic parameters showed no unwanted effects, and mild adverse events were gastrointestinal and resolved spontaneously.

In a randomised, double-blind, placebo-controlled trial, 54 adults aged 65 or over (mean 73.5 years), without clinical signs of dementia, took 300 mg per day of standardised bacopa extract or placebo for 12 weeks; 48 completed the study and tolerability was assessed alongside cognitive function. More recently, a randomised, double-blind, placebo-controlled trial followed 101 adults aged 40 to 70 with subjective complaints of memory and attention for 12 weeks, with 300 mg daily of a bacopa extract or placebo.

A 2023 systematic review of plants and nutrients for cognitive function in older adults, with and without subjective cognitive complaints, included 21 randomised trials and also assessed the safety of those interventions. And a 2021 review of plants with nootropic effects includes bacopa among the most prevalent botanicals in the brain-supplement market, analysing efficacy data for cognitive function.

What these data do not answer: there are no long-term toxicity studies in humans, so the safety of continued use over years remains unknown. That is an honest gap, not a hidden danger — but it is a gap.

What does "too much" actually mean with bacopa?

There is no established tolerable upper intake level for bacopa, and no official safe ceiling. The trials used 300 mg per day of standardised extract in adults, with the phase I study going up to 450 mg per day for 15 days without unwanted effects on the parameters measured. Those are study doses, not a target for you to chase.

A tolerable upper level, where one exists for a nutrient, is the amount unlikely to cause harm over a lifetime in the general population. A dangerous dose is something else entirely — the amount that causes clear harm. For bacopa, neither figure is established in the sources available. What we can say is that the gap between the studied dose and an unknown risk is not a licence to take more. If you are considering exceeding the label dose, that is a conversation for a pharmacist or doctor, not a decision to make alone.

Which side effects are most common?

The most frequent effects are gastrointestinal. In the phase I study with healthy adults, the mild adverse events observed were related to the gastrointestinal system, and they disappeared without intervention. In practice, this means nausea, cramps, dry mouth or looser stools, especially in the first few days.

There are also reports of tiredness or drowsiness in some people, particularly when the dose is taken at night. It is not described as dangerous, but it can be inconvenient. If it happens, try moving the dose earlier or taking it with a meal.

These symptoms tend to be mild and transient. If they persist for more than two weeks or get worse, stop and speak to a healthcare professional.

Who should be cautious or avoid bacopa?

Some groups warrant more caution — not because a documented danger exists, but because data are lacking.

• Pregnant and breastfeeding women: the 2025 review of bacopa stresses the need for more research to determine optimal doses and ensure safety, especially in these groups.
• People with hyperthyroidism or taking thyroid medication: the same review indicates that interactions with certain medicines and contraindications in situations such as hyperthyroidism should be considered.
• Children and adolescents: studies exist in this age group, but they are few and of varied design. A systematic review identified five studies in children and adolescents, with consistent improvements in the cognitive domain of language/behaviour and in several memory subdomains, as well as in hyperactivity and attention. An open-label trial in 31 children with ADHD, aged 6 to 12, used 225 mg per day for 6 months; this is a specific clinical population and an uncontrolled study, so it should not be read as a general recommendation. In any case, children and adolescents should not take bacopa supplements without guidance from a healthcare professional.
• People with a chronic illness, taking regular medication or scheduled for surgery: they should speak to their doctor or pharmacist before starting.

Anyone with gastric ulcers or inflammatory bowel disease should be equally cautious: bacopa may increase acid secretion in the stomach, which can aggravate these conditions. If you have an autoimmune disease, such as lupus or rheumatoid arthritis, you should also speak to your doctor first — there are no safety data in these situations and the plant may act on the immune system.

Interactions with medicines: what is known

The 2025 review of bacopa states explicitly that interactions with certain medicines and contraindications in conditions such as hyperthyroidism should be considered. This is particularly relevant for anyone taking levothyroxine or other thyroid drugs.

In addition, because bacopa acts on the central nervous system, there is a theoretical possibility that it could enhance the effect of sedatives, anxiolytics and antidepressants. The available summaries do not contain data quantifying that risk, so the advice is caution and medical supervision if you are taking any of these medicines.

If you take anticoagulants, antiepileptics or drugs with a narrow therapeutic margin, the conversation with your doctor matters even more. Not because a serious interaction is documented in the summaries, but because the available information is insufficient to rule out risk.

There are no known serious interactions with alcohol or caffeine, but common sense recommends moderation. Bacopa is not an inert substance: it is a plant with pharmacological effects.

Bacopa in gummies: what changes on the label

The gummy format does not change the safety of bacopa itself, but it changes what is on the label. Focus & Concentration Gummies provide 150 mg of bacopa extract per 2-gummy serving, among other ingredients. The trials we referred to used 300 mg per day; the label's daily dose (150 mg, corresponding to 2 gummies) is therefore half that used in those studies — and study doses are not dosing instructions.

The directions say to chew 2 gummies per day, preferably after a meal, without exceeding the recommended daily dose. The product warnings state that it is intended for adults, should not be consumed by children, is not recommended for pregnant or breastfeeding women, and that in case of illness or use of medication you should consult a healthcare professional before consumption. The product contains polyols, and excessive consumption may have laxative effects.

That last point matters for the "is it bad for you?" question: in people sensitive to polyols, the gummy may cause digestive discomfort regardless of the bacopa. Keep the bottle out of reach of young children, because the gummies look like sweets.

The gummies contain maltitol, a polyol; besides the possible laxative effect in excessive consumption, anyone managing their weight or diabetes should check the label. Chewing gummies every day also increases the risk of tooth decay, so brushing your teeth after taking them is good practice. And if you are weighing up formats, the format comparison is where that decision belongs.

Bacopa and cognitive function: what the trials measured

You cannot talk about safety without framing what the plant is for. Bacopa has been studied mainly for memory and attention. In the trial in older adults, the primary measure was delayed recall in a verbal learning test, in a 12-week treatment trial. In the more recent trial, participants had subjective complaints of memory and attention and were assessed on verbal learning, attention and working-memory tasks, also over 12 weeks.

A 2021 systematic review of supplement ingredients for cognitive performance in healthy adults included bacopa among ingredients with at least three published studies, but concluded that the level of certainty in the science is low. That means the effects, where they exist, are modest and variable — it is not a substance with guaranteed results.

For a more detailed look at what the science shows and what remains unproven, see the article on bacopa benefits. This page stays on safety.

Common myths about bacopa's safety

"Bacopa is addictive"

There is no evidence in the available summaries that bacopa causes dependence or withdrawal syndrome.

"Bacopa is toxic to the liver"

Reviews describe the plant as generally non-toxic and without serious side effects reported. In the available summaries, no cases of hepatotoxicity at normal doses are reported. This does not rule out risk at extreme doses or in people with pre-existing liver disease, but it is not a concern for most people.

"Bacopa is a strong sedative"

Bacopa acts on the central nervous system through several mechanisms, but there are not enough data in the available summaries to classify it as a clinical sedative. Some people report drowsiness, especially if they take it at night. If that happens, adjust the timing — the timing article covers the options.

"Bacopa works from day one"

The trials that showed cognitive effects ran for 12 weeks. There is no evidence of an immediate effect. If you expect results on the first day, you will probably be disappointed.

Warning signs: when to stop and seek help

Most effects are mild and transient. But some signs should not be ignored:

• Palpitations, severe dizziness or difficulty breathing.
• Skin rash, swelling of the face or lips.
• Persistent vomiting or bloody diarrhoea.
• Unusual mood changes, such as extreme agitation or deep sadness.

If any of these occur, stop taking it and seek medical help. If you suspect an accidental overdose — for example, a child who has eaten several gummies — contact a healthcare professional or your regional poisons information service immediately. These are the signals that separate a routine, harmless effect from one that needs attention.

How to use bacopa with caution

If you are thinking of starting, the first step is to speak to a pharmacist or doctor, especially if you have a health condition or take medication. Start with the dose stated on the label and watch how your body reacts in the first two weeks. If you feel digestive discomfort, take it with food; if you feel drowsy, adjust the timing.

To understand what dose makes sense and what the known maximum is, see the article on daily bacopa dose. To understand the mechanism behind the effects, read how bacopa works. And if you are deciding between formats, compare bacopa in gummy or tablet form.

One last honest limit: the absence of long-term human toxicity data is a real unknown. That is not a reason to panic, and it is not a reason to assume safety either. It is a reason to keep the conversation open with a professional who knows your history.